Home › Funds › Champlain Investment Partners, LLC › ATRC

Champlain Investment Partners, LLC position in ATRC

ATRICURE INC · Health Care

Champlain Investment Partners, LLC reported holding 466,167 shares of ATRC (ATRICURE INC) in its Q3 2026 13F filing — a position valued at US$26.2M, representing 0.90% of its reported portfolio and ranking #39 among its reported holdings. Champlain Investment Partners, LLC has disclosed ATRC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)466.17K sh
Reported value held$26.20M
Portfolio Weight0.90%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Champlain Investment Partners, LLC's ATRC position evolved

Champlain Investment Partners, LLC first disclosed a stake in ATRC in Q3 2023 at 1,851,540 shares (US$81.1M). The position peaked in Q1 2024 at 2,681,000 shares, worth US$81.6M. Across 13 filings, Champlain Investment Partners, LLC increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 466,167 shares valued at US$26.2M — a reduction of -472,400 shares quarter over quarter.. Notable position changes include a 27% increase in Q1 2024 (shares fell 25% over the following quarter), a 41% trim in Q4 2025 (shares fell 28% over the following quarter), a 50% trim in Q3 2026 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.85M $81.10M New
Q4 2023 2.11M $75.14M Add
Q1 2024 2.68M $81.56M Add
Q2 2024 2.67M $60.91M Hold
Q3 2024 2.79M $78.25M Add
Q4 2024 2.53M $77.27M Reduce
Q1 2025 2.14M $68.97M Reduce
Q2 2025 2.02M $66.09M Reduce
Q3 2025 1.98M $69.73M Reduce
Q4 2025 1.17M $46.43M Reduce
Q1 2026 971.11K $27.71M Reduce
Q2 2026 938.57K $26.26M Reduce
Q3 2026 466.17K $26.20M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ATRC and 13F data

ATRC (ATRICURE INC) is a Health Care company. 31 other funds we track also report a position in ATRC — the largest reported positions include KENNEDY CAPITAL MANAGEMENT LLC (US$39.2M), Divisadero Street Capital Management, LP (US$22.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ATRC

All ATRC fund holders →

FAQ

How long has Champlain Investment Partners, LLC held ATRC?

Champlain Investment Partners, LLC has disclosed ATRC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Champlain Investment Partners, LLC's current position in ATRC?

As of Q3 2026, Champlain Investment Partners, LLC holds 466.17K shares of ATRC (ATRICURE INC), valued at $26.20M, representing 0.90% of its reported portfolio and ranking #39.

Has Champlain Investment Partners, LLC been buying or selling ATRC?

In the latest 13F filing (Q3 2026), Champlain Investment Partners, LLC reduced its position in ATRC. The position peaked in Q1 2024 at 2.68M shares.

Which other funds hold ATRC?

Other major institutional holders of ATRC include KENNEDY CAPITAL MANAGEMENT LLC, Divisadero Street Capital Management, LP, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.